1. A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors. Issue 4 (9th May 2014) Authors: Moore, Kathleen; Infante, Jeffrey R.; Cotreau, Monette M.; Wilson, Lindsey; Strahs, Andrew L.; Vargo, Dennis L.; Chadha, Manpreet Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 4(2014:Jul./Aug.) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. Issue 9 (15th July 2022) Authors: Koury, Mark J.; Agarwal, Rajiv; Chertow, Glenn M.; Eckardt, Kai‐Uwe; Fishbane, Steven; Ganz, Tomas; Haase, Volker H.; Hanudel, Mark R.; Parfrey, Patrick S.; Pergola, Pablo E.; Roy‐Chaudhury, Prabir; Tumlin, James A.; Anders, Robert; Farag, Youssef M. K.; Luo, Wenli; Minga, Todd; Solinsky, Christi... Journal: American journal of hematology Issue: Volume 97:Issue 9(2022) Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The effect of food on the pharmacokinetics of tivozanib hydrochloride. Issue 2 (30th October 2013) Authors: Cotreau, Monette M.; Massmanian, Lisa; Strahs, Andrew L.; Slichenmyer, William; Vargo, Dennis L. Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 2(2014:Mar./Apr.) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗